Johnson & Johnson (JNJ) has seen a significant 25% share price increase in 2026, outperforming the S&P 500 amid strong earnings momentum following its recent financial results. In the latest quarter, the company reported sales of $25.3 billion, a record high that reflects a 6.6% year-over-year growth, and revised its fiscal year sales and adjusted earnings per share (EPS) guidance upward, targeting over $100 billion in annual revenue for the first time.
The firm has a long-standing reputation for consistent dividend increases, marking it as a notable Dividend Aristocrat for investors seeking stable income streams.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
